Skip to Content

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

For important updates on recent policy changes, please click here for more details.

Merck
CN
All Photos(1)

Key Documents

View All Documentation

Y0001519

Pioglitazone for system suitability

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Pioglitazone hydrochloride, 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride

Sign Into View Organizational & Contract Pricing

Select a Size

100 MG
CN¥3,469.86

CN¥3,469.86

Please contact Customer Service for Availability
Request a Bulk Order
All Photos(1)

Select a Size

Change View
100 MG
CN¥3,469.86

About This Item

Empirical Formula (Hill Notation):
C19H20N2O3S · HCl
CAS Number:
112529-15-4
Molecular Weight:
392.90
MDL number:
MFCD04975446
UNSPSC Code:
41116107
PubChem Substance ID:
329831470
NACRES:
NA.24

CN¥3,469.86

Please contact Customer Service for Availability
Request a Bulk Order

grade

pharmaceutical primary standard

API family

pioglitazone

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Cl.CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1

InChI

1S/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H

InChI key

GHUUBYQTCDQWRA-UHFFFAOYSA-N

Gene Information

human ... PPARG(5468)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
271508265774875
6,8-Dihydroxy-1,3-pyrenedisulfonic acid disodium salt BioReagent, suitable for fluorescence, ≥97.0% (HPCE)

37920

6,8-Dihydroxy-1,3-pyrenedisulfonic acid disodium salt

Chromotropic acid disodium salt dihydrate puriss. p.a., ACS reagent, for the detection of Ag, ClO3-, Cr, Hg, NO2-, NO32-, Ti, ≥98.0%

27150

Chromotropic acid disodium salt dihydrate

1-Pyrenesulfonic acid sodium salt suitable for fluorescence, ≥97.0% (HPLC)

82657

1-Pyrenesulfonic acid sodium salt

8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt suitable for fluorescence, ≥90% (HPCE)

74875

8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt

Quality Level

100

Quality Level

200

Quality Level

100

Quality Level

100

solubility

DMF: soluble, methanol: soluble, H2O: soluble

solubility

-

solubility

-

solubility

DMF: soluble, DMSO: soluble, H2O: soluble, methanol: soluble

mp

≥250 °C (lit.)

mp

>300 °C (lit.)

mp

233-236 °C (lit.)

mp

251-260 °C (lit.)

form

powder

form

powder

form

powder

form

powder

product line

BioReagent

product line

-

product line

-

product line

-

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Pioglitazone for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem/physiol Actions

Pioglitazone hydrochloride is a PPARγ agonist and thiazolidinedione (TZD) anti-diabetic.
Pioglitazone hydrochloride is a PPARγ agonist and thiazolidinedione (TZD) anti-diabetic. Pioglitazone is a selective agonist of the nuclear receptor peroxisome proliferator-activated receptor γ (PPAR-γ) and to a lesser extent PPAR-α.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Pictograms

Health hazardExclamation mark
GHS08,GHS07

Signal Word

Warning

Hazard Statements

H302,H351

Hazard Classifications

Acute Tox. 4 Oral - Carc. 2

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

  • Specification Sheet

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: an effect mediated through cytokines, antioxidants and lipid biomarkers.
    Niture NT, Ansari AA, and Naik SR
    Indian Journal of Experimental Biology, 52(7), 720-727 (2014)
    Chin-Hsiao Tseng
    Metabolism: clinical and experimental, 63(8), 1049-1055 (2014-06-04)
    To investigate whether pioglitazone treatment of patients with type 2 diabetes mellitus was associated with an increased risk of kidney cancer. The reimbursement databases of all Taiwanese patients with type 2 diabetes who received oral anti-diabetic agents or insulin from
    W Xu et al.
    Journal of internal medicine, 277(1), 137-150 (2014-07-22)
    Progressive β-cell dysfunction hinders the maintenance of glycaemic control in type 2 diabetes, but comparative data on β-cell-protective therapies are lacking in the early stage of type 2 diabetes. Here we evaluated the comparative glycaemic efficacy and impact on β-cell
    Xiao-qing Chen et al.
    Experimental cell research, 330(1), 43-55 (2014-08-26)
    The exact mechanisms underlying inhibitory effects of pioglitazone (Pio) on Angiotensin II (AngII)-induced atrial fibrosis are complex and remain largely unknown. In the present study, we examined the effect of Pio on AngII-induced mice atrial fibrosis in vivo and atrial
    M Suzuki et al.
    Nutrition & diabetes, 4, e125-e125 (2014-07-08)
    Tofogliflozin, a highly selective inhibitor of sodium/glucose cotransporter 2 (SGLT2), induces urinary glucose excretion (UGE), improves hyperglycemia and reduces body weight in patients with Type 2 diabetes (T2D). The mechanisms of tofogliflozin on body weight reduction were investigated in detail
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service